FDA approves heartburn treatment Kapidex

02/1/2009 | Bloomberg · Chicago Tribune (tiered subscription model)

The FDA has cleared Kapidex, a capsule to treat gastroesophageal reflux disease that releases the drug in two stages, to spread out the dose evenly. An eight-week trial found a 60-milligram dosage of Kapidex resulted in comparable overall healing rates compared to a 30-milligram dosage of Prevacid.

View Full Article in:

Bloomberg · Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ